➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: March 8, 2021

DrugPatentWatch Database Preview

Zydus Pharms Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ZYDUS PHARMS, and what generic and branded alternatives to ZYDUS PHARMS drugs are available?

ZYDUS PHARMS has two hundred and ten approved drugs.

There are seventeen tentative approvals on ZYDUS PHARMS drugs.

Summary for Zydus Pharms
US Patents:0

Drugs and US Patents for Zydus Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms DOXYCYCLINE doxycycline CAPSULE;ORAL 205115-001 Feb 18, 2016 AB RX No No   Start Trial   Start Trial
Zydus Pharms ENTECAVIR entecavir TABLET;ORAL 206745-001 Jun 23, 2017 AB RX No No   Start Trial   Start Trial
Zydus Pharms ATAZANAVIR SULFATE atazanavir sulfate CAPSULE;ORAL 210575-003 Jun 4, 2020 DISCN No No   Start Trial   Start Trial
Zydus Pharms SEVELAMER CARBONATE sevelamer carbonate TABLET;ORAL 207759-001 Aug 11, 2020 AB RX No No   Start Trial   Start Trial
Zydus Pharms POTASSIUM CHLORIDE potassium chloride TABLET, EXTENDED RELEASE;ORAL 210395-001 Sep 17, 2020 AB1 RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for ZYDUS PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.